中国医药 (600056.SH) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

13.3x

Market Cap

CNY 13.72B

MomentumView details →

1D Return

−0.33%

YTD Return

−12.29%

RSI (14)

40.7

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

13.3x

Market Cap

CNY 13.72B

RSI (14)

40.7

MomentumView details →

1D Return

−0.33%

YTD Return

−12.29%

ProfitabilityView details →

Gross Margin

10.51%

Net Margin

1.38%

EBITDA Margin

4.09%

ROE (TTM)

4.02%

ROA (TTM)

1.29%

Asset Turnover

0.94x

GrowthView details →

Revenue YoY

+0.08%

EPS YoY

−20.80%

FCF YoY

+177.90%

Revenue CAGR 3Y

−2.02%

EPS CAGR 3Y

−13.67%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.45x

Current Ratio

1.42x

Quick Ratio

1.11x

Div Yield

1.05%

Div Rate

CNY 0.09

Div Growth 1Y

−28.54%

Financials snapshotView financials →

Revenue (TTM)

35.02B

Net Income (TTM)

482.86M

Op. CF (TTM)

1.48B

Latest newsMore news →

China Meheco issued 1 billion yuan in corporate bonds and increased bank borrowings, resulting in net financing cash inflow of 773 million yuan.10d ago

China Meheco Co., Ltd. announced its first-half 2026 results: net profit attributable to shareholders was 249 million yuan, down 15.26% year-on-year.10d ago

Similar companies

辽宁成大600739.SH Henry Schein, Inc.HSIC 国药股份600511.SH 九州通600998.SH 南京医药600713.SH 柳药集团603368.SH Find similar companies →

Latest newsMore news →

China Meheco issued 1 billion yuan in corporate bonds and increased bank borrowings, resulting in net financing cash inflow of 773 million yuan.10d ago China Meheco Co., Ltd. announced its first-half 2026 results: net profit attributable to shareholders was 249 million yuan, down 15.26% year-on-year.10d ago